Intronix Technologies Corporation

Intronix Technologies Corporation designs and produces software for patients and clinicians to help manage chronic pain; As well as our well known hand-held "Myoguide" EMG/ STIM injection guidance device for use with toxin and neurolytic drugs used to help manage patients with spasticity and pain. Myoguide was designed to be continuously upgradable within the scope of its operation, ensuring our devices can evolve with new clinical demands and technology. We continue to support Myoguide despite a critical supply chain crash halting production in 2020. We currently offer several eLearning courses for healthcare providers through the Myoguide Academy. Our courses are aimed at helping clinicians improve the quality and precision of their therapeutic or aesthetic injections via interactive anatomical content. Our premium courses include access to 3D-anatomical models. Intronix products enable clinicians to improve diagnosis, treatment planning, boost treatment efficacy and provide accurate follow-up assessment of movement disorders, myofascial pain, spasticity, and fibromyalgia. Our work also involves supporting pain patients directly, through our free patient resource page: The I-Engage Academy. The I-Engage Academy shares eLearning courses, follow-along videos, and blog posts that are designed to help people with chronic pain develop new pain management skills.

• Employees4
• Founded1984
• Annual Revenue$3041000